Web-based Validation Pelvic Floor Questionnaires
Validation of Electronic (Web-based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction
1 other identifier
observational
90
2 countries
5
Brief Summary
Patient-reported outcomes are commonly used in healthcare. Examples include validated symptom-based questionnaires and health diaries. In the field of Female Pelvic Medicine and Reconstructive Surgery there are many questionnaires and diaries that have been validated for a paper-based administration. As technology is incorporated into delivery of medical care and research, investigators need to consider how to collect data electronically while ensuring that this new format is equivalent to the paper questionnaires they rely on. In this study, the investigators aim to validate a series of validated questionnaires and symptom diaries administered via the web and smartphone for a more streamlined care for the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2015
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 4, 2016
CompletedFirst Posted
Study publicly available on registry
March 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedApril 1, 2019
March 1, 2019
3.7 years
February 4, 2016
March 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Test-retest reliability of PFDI-20 in the electronic format
Subjects will complete the paper and either web-based or smartphone versions of the PFDI-20 with at least a 2 week interval between administration of the 2 versions.
minimum 2 week interval until subject receives treatment for the condition or up to one year
Test-retest reliability of PFIQ-7 in the electronic format
Subjects will complete the paper and either web-based or smartphone versions of the PFIQ-7 with at least a 2 week interval between administration of the 2 versions.
minimum 2 week interval until subject receives treatment for the condition or up to one year
Test-retest reliability of PISQ-12 in the electronic format
Subjects will complete the paper and either web-based or smartphone versions of the PISQ-12 with at least a 2 week interval between administration of the 2 versions.
minimum 2 week interval until subject receives treatment for the condition or up to one year
Test-retest reliability of BSS in the electronic format
Subjects will complete the paper and either web-based or smartphone versions of the BSS with at least a 2 week interval between administration of the 2 versions.
minimum 2 week interval until subject receives treatment for the condition or up to one year
Study Arms (2)
Arm 1 paper form first
paper questionnaires first then web/smart phone questionnaires after a 2-week washout period
Arm 2 web/smartphone form first
web/smart phone questionnaires first then paper questionnaires after a 2-week washout period
Interventions
questionnaires in web/smartphone
Eligibility Criteria
This is a prospective validation study. Subjects will be recruited at their visit to the Female Pelvic Medicine and Reconstructive Surgery offices and clinics at Columbia and Cornell. Demographic information will be collected at the initial visit/enrollment including age, race, parity, and presenting complaint. Questionnaires will be administered based on a randomization scheme. These include: * Pelvic Floor Disorders Inventory short form (PFDI-20) * Pelvic Floor Impact Questionnaire (PFIQ-7) * Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) * Bristol Stool Scale (BSS) Questionnaires will be administered via paper-based form, web-based, or smartphone app based on randomization scheme.
You may qualify if:
- Women at least 18 years of age presenting with pelvic floor dysfunction
You may not qualify if:
- Unable to repeat questionnaires or return to the office in 2 weeks
- No access to computer/web or smartphone
- Pregnancy (as gestational age will advance during 2 week time interval and symptoms may change)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- University of Wisconsin, Madisoncollaborator
- University of Arkansascollaborator
- The Methodist Hospital Research Institutecollaborator
- University of Calgarycollaborator
Study Sites (5)
University of Arkansas
Fayetteville, Arkansas, 72701, United States
Columbia University Irving Medical Center
New York, New York, 10032, United States
Houston Methodist Hospital
Houston, Texas, 77030, United States
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, 53726, United States
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Related Publications (1)
Grimes CL, Antosh DD, Oliphant S, Yurteri-Kaplan L, Kim-Fine S, Melamud G, Heisler C, Chung DE; Collaborative Research in Pelvic Surgery Consortium (CoRPS). Correlation of Electronic (Web-Based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction: A Randomized Controlled Trial. Female Pelvic Med Reconstr Surg. 2020 Jun;26(6):396-400. doi: 10.1097/SPV.0000000000000713.
PMID: 30889034DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Cara Grimes, MD
Columbia University
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2016
First Posted
March 31, 2016
Study Start
February 1, 2015
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
April 1, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share